The influence of low dose finasteride, a type II 5α-reductase inhibitor, on circulating neuroactive steroids

@inproceedings{Dukov2010TheIO,
  title={The influence of low dose finasteride, a type II 5α-reductase inhibitor, on circulating neuroactive steroids},
  author={M. Du{\vs}kov{\'a} and M. Hill and Ľ. St{\'a}rka},
  booktitle={Hormone molecular biology and clinical investigation},
  year={2010}
}
  • M. Dušková, M. Hill, Ľ. Stárka
  • Published in
    Hormone molecular biology and…
    2010
  • Biology, Medicine
  • Abstract Background: Finasteride is a 5α-reductase inhibitor that has received clinical approval for the treatment of human benign prostatic hyperplasia and androgenetic alopecia. The treatment is practically without side effects, although some occasional cases of depression syndrome have been reported. 5α-Reductase is an enzyme responsible for the reduction of testosterone, progesterone or deoxycorticosterone to their 5α-reduced derivatives possessing anticonvulsant, antidepressant, and… CONTINUE READING
    1 Citations
    Neuroactive Steroids and Affective Symptoms in Women Across the Weight Spectrum
    • 17
    • PDF

    References

    SHOWING 1-10 OF 26 REFERENCES
    Clinical and endocrine effects of finasteride, a 5 alpha-reductase inhibitor, in women with idiopathic hirsutism.
    • 71
    • Highly Influential
    A new look at the 5alpha-reductase inhibitor finasteride.
    • 117
    A New Look at the 5á-Reductase Inhibitor Finasteride
    • 31
    Finasteride: the first 5 alpha-reductase inhibitor.
    • 51
    Finasteride induced depression: a prospective study
    • 93
    • PDF
    Finasteride, a Type 2 5alpha-reductase inhibitor, in the treatment of men with androgenetic alopecia.
    • 33
    Finasteride-Induced Myalgia and HyperCKemia
    • 9
    Depression Circumstantially Related to the Administration of Finasteride for Androgenetic Alopecia
    • 83